Sulfatrim and Dyspnoea exertional for Women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Dyspnoea exertional is found for women aged 60+ who take Sulfatrim (sulfamethoxazole; trimethoprim). This study is created by eHealthMe based on reports of 836 women aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Sulfatrim when people have Dyspnoea exertional
Top conditions
Top co-used drugs
Top other side effects

On Jan, 18, 2026

836 women aged 60+ reported to have side effects when taking Sulfatrim.
Among them, 43 people (5.14%) have Dyspnoea exertional

What is Sulfatrim?

Sulfatrim has active ingredients of sulfamethoxazole; trimethoprim. eHealthMe is studying from 4,140 Sulfatrim users. Check the latest studies of Sulfatrim.

What is Dyspnoea exertional?

Dyspnoea exertional (breathlessness or shortness of breath) is found to be associated with 2,382 drugs and 1,562 conditions by eHealthMe. Check the latest studies of Dyspnoea exertional.

Number of reports submitted per year:

Could Sulfatrim cause Dyspnoea exertional in women aged 60+?

Severity of Dyspnoea exertional

n/a

How people recovered from Dyspnoea exertional

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 18 people, 41.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 37.21%
Urinary Tract Infection: 15 people, 34.88%
Cardiac Disorder: 15 people, 34.88%
Blood Pressure Abnormal: 11 people, 25.58%
High Blood Pressure: 7 people, 16.28%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 6 people, 13.95%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 5 people, 11.63%
Immunodeficiency Disorders: 5 people, 11.63%
High Blood Cholesterol: 3 people, 6.98%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Abdominal Pain: 37 people, 86.05%
Nausea (feeling of having an urge to vomit): 37 people, 86.05%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 35 people, 81.40%
Weight Decreased: 33 people, 76.74%
Joint Swelling: 33 people, 76.74%
Pain: 33 people, 76.74%
Fever: 25 people, 58.14%
Dyspnea (difficult or laboured breathing): 24 people, 55.81%
Fatigue (feeling of tiredness): 24 people, 55.81%
Nausea And Vomiting: 23 people, 53.49%

* Approximation only. Some reports may have incomplete information.

Do you take Sulfatrim and have Dyspnoea exertional?

- Check whether Dyspnoea exertional is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Sulfatrim and Dyspnoea exertional

How the study uses the data?

The study is based on (applicable) gender, age, sulfamethoxazole; trimethoprim (the active ingredients of Sulfatrim) and Sulfatrim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.